A Single Arm, Multicenter Study to Investigate the Efficacy and Safety of Oral Molidustat in Dialysis Subjects With Renal Anemia Who Are Not Treated With Erythropoiesis-Stimulating Agents (ESAs)
Phase of Trial: Phase III
Latest Information Update: 01 Apr 2018
At a glance
- Drugs Molidustat (Primary)
- Indications Anaemia
- Focus Registrational; Therapeutic Use
- Acronyms MIYABI HD-C
- Sponsors Bayer
- 25 Jan 2018 Status changed from not yet recruiting to recruiting.
- 21 Dec 2017 Planned initiation date changed from 1 Dec 2017 to 28 Dec 2017.
- 27 Nov 2017 New trial record